Key Takeaways
- Gurgaon launch validates the model: The first intergenerational community sold 82% of inventory (240 of 292 units) within months, proving strong demand and pulling forward Phase-2 discussions on contiguous land.
- Noida Phase-2 faces a regulatory delay: A RERA-related setback is under appeal, pushing out the timeline, though management expects a much higher price point when resolved.
- AGEasy is scaling fast but burning cash: The D2C business saw a 6x growth in daily run rate with improving efficiency metrics, yet consolidated EBITDA loss widened to Rs 24.7 Cr as the company funds growth.
- The ecosystem flywheel is taking shape: Partnerships with Boat, Dr. Lal PathLabs, Axis Bank, and Axis Max Life are layering services and financing onto the core residence and care platform, aiming for higher customer lifetime value.
- What to watch next quarter: The pace of Noida Phase-2 resolution, the ramp-up of nearly 200 new Care Home beds going live, and whether AGEasy's improving unit economics start to narrow the consolidated loss.
The Gurgaon Launch & Residential Pipeline
- Gurgaon Phase-1 sold 82% in months: 240 of 292 units sold, described as a "phenomenal response" that validates the intergenerational living concept and the pricing power in the NCR market.
- Phase-2 pulled forward by demand: Management is already in discussion with Max Estates for a Phase-2 on a contiguous piece of land, citing pending demand that Phase-1 could not fulfill.
- Dehradun is operationally cash-positive: All inventory sold out, operational revenue grew 13% YoY to Rs. 6.1 Cr, and the community reported a profit of Rs. 0.4 Cr with an overall cash surplus of Rs. 110 Cr.
- Noida Phase-1 collections are ahead of plan: The project is fully sold with 99% collection efficiency and total collections of INR 382 Cr (14% growth), though the OC application is held up by sector-level issues being sorted by the Noida authority.
- Noida Phase-2 is delayed by RERA: The setback is described as temporary, taken up with the appellate authority, with resolution discussions underway; management expects the eventual price point to be much higher than Phase-1.
- Bangalore was dropped over title risk: The company backed out because clearance was not received from the land owners' lenders, and management did not want to enter a risky project.
- Hyderabad and Bangalore deprioritized for Gurgaon: The Gurgaon Phase-2 opportunity came at a price point that was a multiple of what Bangalore or Hyderabad could offer, making it the more attractive financial call.
- Chandigarh is at the definitive agreement stage: Actively pursued, with a commitment to keep creating 0.15 crore square feet every year.
Rajit Mehta: "within the few months we have been able to sell 82% of the inventory, so roughly 240 of the 292 units have been sold."
AGEasy: Growth, Efficiency & the Path to Scale
- Daily run rate grew 6x: The D2C senior-care products business saw non-linear growth, with sharp improvement in return on advertising spend (ROAS) month-on-month and quarter-on-quarter.
- Gross margins are improving structurally: Sourcing from China has begun with an order worth Rs. 5 Cr for 20 products, expected to improve gross margins by about 20%; management targets 55-60% gross margin next year and 60%+ in two years.
- The CM2-positive target is two years out: Management wants the business to be contribution-margin positive including all direct spend within that timeframe, while total cash burn continues to rise in the near term as the business scales.
- Revenue ambition is Rs. 500 Cr before 5 years: The channel mix is expected to evolve from marketplace-heavy today toward 55-45 or 60-40 marketplace vs D2C, eventually settling at roughly 50-40-10.
- New products and offline presence are being tested: 10 new product launches are planned in Q4, a gut health condition launch is expected in Q1 FY26, and the first dedicated AGEasy store opens in a Gurgaon mall within 15 days as a branding pilot.
- Partnerships are layering on distribution and credibility: An exclusive tie-up with Boat for senior-specific electronics, a Dr. Lal PathLabs partnership for customized geriatric diagnostic packages, and an exclusive Well-being Nutrition collaboration for tailored nutraceuticals were all onboarded this quarter.
- The Axis Bank Silver Lining program gives access to 30 lakh senior customers, while an Axis Max Life immediate annuity product has been concluded to help Antara customers finance monthly expenses.
Rajit Mehta: "Absolutely, the it will be Rs. 500 crores before 5 years actually."
Care Homes & Care at Home
- Gurgaon Care Home saw an occupancy dip: Long-term move-ins slowed, and some seniors were lost to age and medical conditions; contribution margins held steady and management calls it a temporary issue that will resolve over time.
- Nearly 200 beds go live in Q4: Three Care Homes in Chennai and one in Bangalore are set to operationalize, part of a 250-300 bed expansion within sight, with full efforts to bring maximum beds online this fiscal year.
- Mature steady-state target is Rs. 5-6 Cr per Care Home annually: Each facility is expected to reach that revenue run-rate once stabilized.
- Care at Home is nearing contribution breakeven in Bangalore and Chennai: Penetration of higher-margin services like Critical Care and Physiotherapy is increasing, improving unit economics.
- Certification standards are being built: The company is working with NABH to create certification standards for Care Homes and Memory Care Homes, and its geriatric care training program content has been certified by the Healthcare Sector Skills Council.
- Dementia care is a growing focus: A collaboration with Dementia India Alliance for protocols and training content, plus a knowledge partnership with NIHMANS, signals investment in specialized memory care capabilities.
The Ecosystem Flywheel & Insurance Catalyst
- The flywheel concept is now explicit: Management describes a model where customers enter through residences, AGEasy, Care Homes, or Care at Home, and are then sold multiple products and services for much higher lifetime value.
- Insurance is the big unlock, and it is being pushed at the policy level: The company is working at the NITI Aayog level and with the Ministry of Social Justice to push the government to create a task force on insurance for senior care, arguing that insurance will be a major demand catalyst once it covers the sector.
- The building blocks are being laid now: The Axis Max Life annuity product, the NABH certification work, and the government engagement are all positioned as preparatory steps so that when insurers enter, Antara is ready with standards, products, and distribution.
- Management is patient on timing: Described as "a question of time before this sector also starts to attract insurer's attention," with no specific timeline committed.
Rajit Mehta: "We have been trying to work both at an NITI Aayog level and Ministry of Social Justice to push the government to create a task force. Because we think insurance, once it comes into play for senior care, will be a big push to the business."
Financials & Cash Burn
- Consolidated revenue declined QoQ: The drop is attributed to the cyclical nature of collections depending on when dues fall due; management calls it temporary and expects it to normalize as more communities are launched and collected.
- Consolidated EBITDA loss widened to Rs. 24.7 Cr from Rs. 15.7 Cr, driven by investment in growth businesses, partially contained by cost optimization and healthy treasury income.
- Cash burn in AGEasy is rising in absolute terms but efficiency is improving in parallel: ROAS, gross margins, and contribution margins are all improving at the same pace as spending increases, with the benefits expected to manifest in coming quarters.
- The path to consolidated breakeven is FY27-FY28: The overall revenue target is Rs. 1,000 Cr topline by FY29-FY30, built on 8 to 10 communities contributing roughly Rs. 250 Cr at healthy EBITDA margins, plus 1,500-2,000 assisted living beds.
Rajit Mehta: "It is just the nature of the business. Nothing to get worried about, it is very temporary, and we have been guiding you all the time this will happen."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Care Home bed additions | Close to 200 beds to go live across 3 Chennai and 1 Bangalore Care Home | Q4 FY25 |
| New product launches | 10 new product launches in AGEasy | Q4 FY25 |
| Gut health condition launch | New condition-specific product line in AGEasy | Q1 FY26 |
| AGEasy gross margin | 55%-60% | Next year (FY26) |
| AGEasy gross margin | 60%+ | Two-year timeframe |
| AGEasy CM2 positive | Contribution margin positive including all direct spend | Two years |
| AGEasy revenue | Rs. 500 crores | Before 5 years |
| Consolidated breakeven | Company-level breakeven | FY27-FY28 |
| Overall topline | Rs. 1,000 crores | FY29-FY30 |
| Community count | 8 to 10 communities at ~Rs. 250 Cr topline with healthy EBITDA margin | By FY29-FY30 |
| Assisted living bed capacity | 1,500-2,000 beds | By FY29-FY30 |
| Land bank commitment | Create 0.15 crore square feet every year | Ongoing annual commitment |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated revenue | ₹39 cr, 18% lower primarily due to cyclical lower collection in residences |
| Consolidated EBITDA loss (excl. exceptional item) | ₹24.7 cr, compared to ₹15.7 cr |
| Treasury and monetizable assets | ₹312 cr as of December 24 |
| Consolidated net worth | ₹400 cr as of December 24 |
| Antara Assisted Care net revenue | ₹19.4 cr, +57% QoQ and +176% YoY |
| Care Home net revenue | ₹2.1 cr, +22% QoQ and +40% YoY |
| Care Home contribution margin | 1% for existing Gurugram and Memory Care Home |
| Care Home margins | 18%, improved from 12% in Q3 FY24 |
| Care at Home revenue | ₹4.6 cr, highest ever, +83% YoY |
| AGEasy net revenue | ₹12.7 cr, highest ever, +92% QoQ |
| AGEasy annual revenue trajectory | ₹60 cr crossed |
| AGEasy monthly revenue rate | ₹3 cr in December, up from ₹52 lakhs in June and ₹1.3 cr in September |
| AGEasy channel mix | 68% marketplaces, 22% D2C, 10% offline |
| AGEasy gross margin target | 55%–60% next year, 60%+ in two years |
| Dehradun operational revenue | ₹6.1 cr, +13% YoY |
| Dehradun community profit | ₹0.4 cr, operationally cash positive |
| Dehradun cash surplus | ₹110 cr |
| Noida Phase-1 total collections | ₹382 cr, +14% YoY, 99% collection efficiency |
| Gurgaon community sales collection | ₹124 cr, 240 of 292 units sold (82%) |
| Care Home beds added in FY25 | 234 beds added, bed capacity now 300 |
| Care Home beds to go live in Q4 | Close to 200 beds across 3 Care Homes in Chennai and 1 in Bangalore |
| ARPOB growth | ~8% |
| AGEasy repeat customers | 18,000 |
| AGEasy lives touched | 1.93 lakh (1.5 lakh via marketplaces) |
| AGEasy NPS | 36, up from 13 six months ago |
| Customer satisfaction scores | 92% Care Homes, 94% Care at Home, 84% AGEasy |
| Resales in 9M FY25 | 12 resales, ₹2.2 cr marketing fee earned |
| China sourcing order placed | ₹5 cr for 20 products, expected to improve margin by ~20% |
| Consolidated breakeven target | FY27–FY28 |
| Revenue aspiration | ₹1,000 cr by FY29–FY30 |